Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanofixit is a nanotechnology company that specializes in the development of liquid glass and antimicrobial coating solutions. Originally established to provide ultra-hard liquid screen protectors for consumer electronics, the company has expanded its focus into the healthcare sector through its Nanofixit Health division. Their core technology utilizes a unique blend of titanium dioxide and silver nanoparticles to create a protective layer that actively eliminates bacteria and viruses upon contact. This platform is applied to a wide range of surfaces, including medical devices, high-touch public areas, and personal protective equipment, to provide long-lasting sanitization. Nanofixit's products are designed to offer a non-toxic, environmentally friendly alternative to traditional chemical disinfectants. The company operates globally, with a significant presence in Southeast Asia and research roots in Scandinavia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanofixit Ventures.